Off-Label HBOT: How to Think About Investigational Uses

Many people first hear about hyperbaric oxygen therapy in the context of conditions it is not FDA-approved to treat. These are called off-label or investigational uses, and the marketing around them can be enthusiastic while the evidence is often preliminary. This page is not a recommendation for or against any off-label use. It is a framework for thinking clearly about investigational HBOT so you can make an informed decision with your doctor. It is general educational information, not medical advice.

What Investigational Means

HBOT is FDA-approved for a specific set of conditions where the evidence and regulatory review support its use, such as certain non-healing wounds, carbon monoxide poisoning, and decompression sickness. Uses outside that approved list are off-label, meaning the therapy is being applied to a condition for which the FDA has not cleared it as safe and effective.

It is important to understand what that does and does not mean. Off-label does not automatically mean useless, since doctors sometimes use approved treatments off-label based on emerging evidence and clinical judgment. But it does mean the rigorous evidence and regulatory review that back the approved uses are not in place for that condition. The FDA has specifically cautioned consumers that some claims made for HBOT are unproven, noting that HBOT devices are not proven to treat conditions like cancer, Lyme disease, autism, or Alzheimer’s disease, in its consumer guidance on hyperbaric oxygen therapy. On this site, every condition page that describes an off-label use is labeled investigational for exactly this reason.

Read the Evidence Honestly

For most off-label uses, the research is at an earlier stage than for the approved indications. There may be small studies, preliminary trials, or mechanistic theories, but preliminary research is not the same as established effectiveness. A few encouraging small studies can later fail to hold up in larger, more rigorous trials, which is why regulators and clinicians wait for stronger evidence before endorsing a use.

When you encounter claims about an off-label use, it helps to ask what the evidence actually is. Is it large, well-designed clinical trials, or is it small studies, anecdotes, and testimonials? Our guide on HBOT clinical trials discusses how to think about the research. Be especially cautious of providers or sources that speak with certainty about benefits the science has not established, since confident marketing is not evidence. The honest position for many off-label uses is that the evidence is preliminary and the question is genuinely unsettled.

Insurance Will Not Cover It

A practical reality of off-label HBOT is financial. Insurance, including Medicare and commercial plans, covers HBOT for approved conditions with proper documentation, but it does not cover off-label, investigational uses. If you pursue HBOT for a condition outside the approved list, you should expect to pay entirely out of pocket, as our guides on insurance coverage and cost explain.

This matters because off-label HBOT can involve many sessions, and the out-of-pocket total can become substantial. Part of evaluating an investigational use is being clear-eyed about that cost and weighing it against uncertain potential benefit. No one can tell you that spending that money will help, precisely because the evidence is unsettled, so the financial decision is yours to make with full awareness that you are paying for something investigational.

Questions to Ask

If you are considering an off-label use, a few questions help you decide with your eyes open. Ask your own doctor what they think of the evidence for your specific condition and whether they would recommend it, since your physician knows your full medical picture. Ask any provider offering the treatment what evidence supports it for your condition, and listen for whether they cite real research or rely on testimonials and confident claims. Ask about the total expected cost, since you will be paying yourself. And ask about the contraindications and risks, because off-label use carries the same physical risks as approved use without the established benefit.

The goal of these questions is not to talk you into or out of anything. It is to make sure that if you choose an investigational use, you do so understanding that the evidence is preliminary, the cost is yours, and the decision should be made with your doctor rather than based on marketing.

Decide With Your Doctor

The single most important step with any off-label HBOT decision is to involve your own physician. Your doctor can weigh the preliminary evidence against your specific condition and health, something a clinic selling the treatment cannot do impartially. They can also help you avoid pursuing an investigational therapy in place of treatments with established evidence for your condition.

Off-label HBOT sits in a genuinely uncertain space, and this page does not try to resolve that uncertainty for you. What it offers is a way to think about it clearly: understand that investigational means the evidence is not established, read the research honestly rather than the marketing, know that you will pay out of pocket, ask the hard questions, and make the decision together with your doctor. That approach protects you whatever you ultimately choose.

Medical Disclaimer: This page provides general educational information about off-label hyperbaric oxygen therapy. It is not medical advice and is not a recommendation for or against any treatment. Discuss any treatment decision with your qualified healthcare provider.

Sources: FDA, Hyperbaric Oxygen Therapy: Get the Facts | Undersea and Hyperbaric Medical Society

Related guides: Does HBOT Work? | HBOT Clinical Trials | Insurance Coverage